• No results found

Evaluation of Commercially Available Reagents for Diagnosis of Histoplasmosis Infection in Immunocompromised Patients

N/A
N/A
Protected

Academic year: 2020

Share "Evaluation of Commercially Available Reagents for Diagnosis of Histoplasmosis Infection in Immunocompromised Patients"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

TABLE 1 Analytical performance characteristics of urine histoplasmaantigen assays
FIG 2 Method comparison of urine histoplasma results for IVD and LDTversus a reference laboratory
FIG 3 Population distribution of histoplasma antigen levels in patients and controls. The boxes indicate the median and the central 50th percentile, while thewhiskers indicate the central 95%.
FIG 5 Serial changes in urine histoplasma antigen levels with various assays.The units on thevalues and U/ml for polyclonal IVD

References

Related documents

In conclusion, this study showed that in a patient group with mainly moderate and severe COPD experience a loss of peripheral muscle strength and endurance, exercise capacity

It was decided that with the presence of such significant red flag signs that she should undergo advanced imaging, in this case an MRI, that revealed an underlying malignancy, which

There are infinitely many principles of justice (conclusion). 24 “These, Socrates, said Parmenides, are a few, and only a few of the difficulties in which we are involved if

19% serve a county. Fourteen per cent of the centers provide service for adjoining states in addition to the states in which they are located; usually these adjoining states have

All the ingredients of HUA- REN peritoneal dialysis fluid are identical to those of Baxter peritoneal dialysis fluid except for the packaging material, in that HUAREN

In this work, we use the relationships between some matrix elements of the electromagnetic current of the plus component, “+” for the rho meson [ 20 ], in order to get

In this study, we designed a biocompatible phospholipid-coated drug-delivery system based on hollow calcium phosphate (HCP) nanoparticles for co-delivery of DOX and